DK419487A - Kombinationspraeparat til thrombosebehandling indeholdende et fibrinolytum og en prostacyklinanalog - Google Patents

Kombinationspraeparat til thrombosebehandling indeholdende et fibrinolytum og en prostacyklinanalog

Info

Publication number
DK419487A
DK419487A DK419487A DK419487A DK419487A DK 419487 A DK419487 A DK 419487A DK 419487 A DK419487 A DK 419487A DK 419487 A DK419487 A DK 419487A DK 419487 A DK419487 A DK 419487A
Authority
DK
Denmark
Prior art keywords
prostacycline
analogue
fibrinolytum
thrombose
combination preparation
Prior art date
Application number
DK419487A
Other languages
English (en)
Other versions
DK419487D0 (da
Inventor
Berthold Baldus
Bernhard Maass
Bernd Mueller
Werner Witt
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK419487A publication Critical patent/DK419487A/da
Publication of DK419487D0 publication Critical patent/DK419487D0/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK419487A 1985-12-13 1987-08-12 Kombinationspraeparat til thrombosebehandling indeholdende et fibrinolytum og en prostacyklinanalog DK419487D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853544663 DE3544663A1 (de) 1985-12-13 1985-12-13 Thrombosebehandlung mit fibrinolytika und prostacyclinen
PCT/DE1986/000516 WO1987003488A1 (fr) 1985-12-13 1986-12-15 Traitement de la thrombose des fibrinolytiques et des prostacyclines

Publications (2)

Publication Number Publication Date
DK419487A true DK419487A (da) 1987-08-12
DK419487D0 DK419487D0 (da) 1987-08-12

Family

ID=6288681

Family Applications (1)

Application Number Title Priority Date Filing Date
DK419487A DK419487D0 (da) 1985-12-13 1987-08-12 Kombinationspraeparat til thrombosebehandling indeholdende et fibrinolytum og en prostacyklinanalog

Country Status (14)

Country Link
US (1) US5316766A (da)
EP (1) EP0228988B1 (da)
JP (1) JPH0764748B2 (da)
AT (1) ATE104151T1 (da)
AU (1) AU610058B2 (da)
CA (1) CA1283357C (da)
DE (2) DE3544663A1 (da)
DK (1) DK419487D0 (da)
ES (1) ES2051695T3 (da)
HU (1) HU206183B (da)
IE (1) IE64462B1 (da)
IL (1) IL80900A (da)
WO (1) WO1987003488A1 (da)
ZA (1) ZA869399B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001355A (en) * 1982-12-14 1999-12-14 Dowdle; Eugene Bernard Davey Pro-tPA for the treatment of thrombosis, embolism and related conditions
GB8619098D0 (en) * 1986-08-05 1986-09-17 Wellcome Found Combination
NZ230742A (en) * 1986-10-09 1991-03-26 Smithkline Beckman Corp Thrombolytic composition comprising a plasminogen activator (tpa, uk or sk) and a thromboxane receptor antagonist; kits thereof; and process for preparation thereof
EP0299376A3 (en) * 1987-07-13 1990-01-24 William Elson Shell Prostanoid compositions and methods for reducing blood vessel dysfunction
AT402262B (de) * 1991-06-20 1997-03-25 Immuno Ag Arzneimittel enthaltend aktiviertes protein c
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6395494B1 (en) 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US5770609A (en) * 1993-01-28 1998-06-23 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6306421B1 (en) 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6663881B2 (en) * 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5595722A (en) * 1993-01-28 1997-01-21 Neorx Corporation Method for identifying an agent which increases TGF-beta levels
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
CA2162586C (en) * 1993-05-13 2006-01-03 David J. Grainger Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
ATE377418T1 (de) 1995-06-07 2007-11-15 Poniard Pharmaceuticals Inc Vorbeugung und behandlung von kardiovaskulären beschwerden mit tamoxifen-analogen
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5978179A (ja) * 1982-10-26 1984-05-04 Sankyo Co Ltd エポキシカルバサイクリン誘導体およびその製造法
WO1986005096A1 (en) * 1985-03-06 1986-09-12 Survival Technology, Inc. Protein absorption enhancing agents
GB8619098D0 (en) * 1986-08-05 1986-09-17 Wellcome Found Combination

Also Published As

Publication number Publication date
EP0228988A1 (de) 1987-07-15
ZA869399B (en) 1987-08-26
HUT44936A (en) 1988-05-30
IE64462B1 (en) 1995-08-09
DE3544663A1 (de) 1987-06-19
ES2051695T3 (es) 1994-07-01
US5316766A (en) 1994-05-31
JPH0764748B2 (ja) 1995-07-12
CA1283357C (en) 1991-04-23
IL80900A0 (en) 1987-03-31
AU6772387A (en) 1987-06-30
IE863249L (en) 1987-06-13
DK419487D0 (da) 1987-08-12
HU206183B (en) 1992-09-28
EP0228988B1 (de) 1994-04-13
ATE104151T1 (de) 1994-04-15
AU610058B2 (en) 1991-05-16
JPS63501951A (ja) 1988-08-04
WO1987003488A1 (fr) 1987-06-18
IL80900A (en) 1991-11-21
DE3689789D1 (de) 1994-05-19

Similar Documents

Publication Publication Date Title
DK419487D0 (da) Kombinationspraeparat til thrombosebehandling indeholdende et fibrinolytum og en prostacyklinanalog
FI882742A7 (fi) Hoitavia aineita ja niitä sisältäviä koostumuksia.
NO863560L (no) Dentalartikler og silanol-grunningsopploesning for bruk paa slike artikler.
DK393384D0 (da) Katode og apparat til katodeforstoevning
DK531885D0 (da) Fremgangsmaade til desinfektion og middel dertil
DK359686A (da) Lyofiliserede emulsionsmidler og fremgangsmaade
ATE78514T1 (de) Fibrinolytisches agens.
DE3882491D1 (de) Bodenstabilisierendes pulverartiges produkt und verwendungsmethode.
NO901141D0 (no) Additiv og fremgangsmaate for behandling av underjordiske formasjoner.
JO1482B1 (en) Therapeutic agents
FI864552A0 (fi) Human-lysozym.
DK96394A (da) 5-Halogenalkylidinimono-1-arylpyrazoler og fremgangsmåde til fremstilling deraf
NO169928C (no) Fremgangsmaate og anordning for sammenfoeyning av profilseksjoner
ZA857721B (en) Process for treatment of rheumatic diseases
NO881713D0 (no) Fremgangsmaate for fremstilling av di-t-butylfenyl-alkyl og benzylethere.
NO882336L (no) Fremgangsmaate for fremstilling av 5-metoksyalkylammoniun-tetrahydrofuraner og tetrahydrotiofener.
NO882674L (no) Fremgangsmaate for reduksjon av karbamatinnholdet av produkter fremstilt av cellulosekarbamat og produkter fremstiltved fremgangsmaaten.
DK162779C (da) Indretning og fremgangsmaade til antikorrosionsbehandling
NO884818D0 (no) Fremgangsmaate og mellomprodukter for fremstilling av halogenerte proteasehemmere.
NO844548L (no) Fremgangsmaate og apparat for dosering av pulverformige materialer.
NO861083L (no) Analogifremgangsmaate og fremstilling av imidazoisokinoliner og imidazo-tienopyridin-forbindelser.
NO860584L (no) Fremgangsmaate og anordning for stoeping av jern som er blitt behandlet med magnesium.
DK564188D0 (da) Fremgangsmaade og anlaeg til kompostering
GB8729067D0 (en) Treatment of timber
NO871797D0 (no) Fremgangsmaate og anordning for anbringelse av blindnagler.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment